Naftohydrofuryl oxalate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isosorbide mononitrato. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes KCI. It belongs to K deficiency category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ketoprofen. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes lansoprazolo. It belongs to antiulerative category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes mebeverine HCI. It belongs to antispasmodic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes meclozine. It belongs to anti emetic / antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nicardipina. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine + atenolol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitrofurantoin. It belongs to antibacteral category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitroglycerin. It belongs to antianginal/ vasodiolator coronary category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes norphenephrine HCI. It is used for treatment of hipotensive states. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.